Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bilirubin | 23 | 2020 | 438 | 4.180 |
Why?
|
Hepatitis | 3 | 2023 | 231 | 1.590 |
Why?
|
Esophageal and Gastric Varices | 3 | 2022 | 208 | 1.470 |
Why?
|
Hyperbilirubinemia | 3 | 2020 | 74 | 1.180 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 3 | 2017 | 694 | 1.100 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2015 | 514 | 0.960 |
Why?
|
Liver Cirrhosis | 6 | 2024 | 1925 | 0.900 |
Why?
|
HIV Protease Inhibitors | 2 | 2020 | 432 | 0.770 |
Why?
|
Nail Diseases | 1 | 2021 | 55 | 0.760 |
Why?
|
Nails | 1 | 2021 | 295 | 0.680 |
Why?
|
Echocardiography, Transesophageal | 2 | 2022 | 1108 | 0.600 |
Why?
|
Lipid Bilayers | 5 | 2001 | 383 | 0.590 |
Why?
|
Hepacivirus | 3 | 2018 | 1332 | 0.580 |
Why?
|
Cell Movement | 3 | 2017 | 5209 | 0.490 |
Why?
|
Receptors, LDL | 1 | 2017 | 491 | 0.470 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2020 | 1132 | 0.430 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1128 | 0.430 |
Why?
|
Conflict of Interest | 1 | 2018 | 549 | 0.430 |
Why?
|
Liver Diseases | 3 | 2024 | 1297 | 0.390 |
Why?
|
Toll-Like Receptor 4 | 1 | 2015 | 580 | 0.390 |
Why?
|
Liver | 13 | 2023 | 7514 | 0.390 |
Why?
|
Antioxidants | 2 | 2017 | 1668 | 0.360 |
Why?
|
Taurocholic Acid | 1 | 2010 | 43 | 0.360 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 2 | 2002 | 94 | 0.360 |
Why?
|
Hepatitis B, Chronic | 2 | 2006 | 402 | 0.350 |
Why?
|
Genes, APC | 1 | 2010 | 145 | 0.340 |
Why?
|
Up-Regulation | 2 | 2015 | 4132 | 0.330 |
Why?
|
Monocytes | 1 | 2017 | 2575 | 0.290 |
Why?
|
Giant Cells | 1 | 2008 | 185 | 0.290 |
Why?
|
Intestinal Neoplasms | 1 | 2010 | 311 | 0.290 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 2135 | 0.290 |
Why?
|
Ammonia | 2 | 2007 | 236 | 0.290 |
Why?
|
Colitis | 1 | 2015 | 1230 | 0.280 |
Why?
|
Carnitine | 1 | 2007 | 252 | 0.270 |
Why?
|
Serum Albumin | 3 | 2000 | 675 | 0.270 |
Why?
|
Hepatitis C | 3 | 2018 | 1578 | 0.260 |
Why?
|
Plaque, Atherosclerotic | 1 | 2017 | 1517 | 0.250 |
Why?
|
Hepatitis, Autoimmune | 1 | 2008 | 173 | 0.250 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 854 | 0.250 |
Why?
|
Lamivudine | 2 | 2006 | 363 | 0.250 |
Why?
|
Methylprednisolone | 2 | 2021 | 384 | 0.240 |
Why?
|
Intracellular Membranes | 3 | 2002 | 389 | 0.240 |
Why?
|
Fatty Acids | 3 | 2007 | 1805 | 0.230 |
Why?
|
Phosphatidylcholines | 5 | 2001 | 406 | 0.220 |
Why?
|
Leukocytes | 2 | 2015 | 2030 | 0.210 |
Why?
|
Rats, Gunn | 3 | 2010 | 11 | 0.210 |
Why?
|
Alanine Transaminase | 2 | 2024 | 607 | 0.210 |
Why?
|
Circoviridae | 1 | 2001 | 3 | 0.200 |
Why?
|
Hepatitis Viruses | 1 | 2001 | 15 | 0.200 |
Why?
|
Circoviridae Infections | 1 | 2001 | 5 | 0.200 |
Why?
|
Endotoxins | 1 | 2004 | 521 | 0.200 |
Why?
|
Adenoma | 2 | 2010 | 2145 | 0.200 |
Why?
|
Indinavir | 1 | 2001 | 73 | 0.200 |
Why?
|
Fluorescence | 2 | 2001 | 750 | 0.190 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2021 | 366 | 0.190 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 908 | 0.190 |
Why?
|
Membrane Potentials | 1 | 2004 | 1095 | 0.190 |
Why?
|
Malnutrition | 1 | 2007 | 638 | 0.190 |
Why?
|
Hepatitis, Viral, Human | 1 | 2001 | 141 | 0.190 |
Why?
|
Stearic Acids | 1 | 2001 | 56 | 0.190 |
Why?
|
Paracentesis | 1 | 2001 | 98 | 0.180 |
Why?
|
Hepatitis B Vaccines | 1 | 2001 | 185 | 0.170 |
Why?
|
Phospholipids | 2 | 2001 | 788 | 0.170 |
Why?
|
Insulin Resistance | 2 | 2024 | 3959 | 0.170 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2002 | 618 | 0.170 |
Why?
|
Neoplasm Proteins | 2 | 2002 | 3613 | 0.160 |
Why?
|
Rats | 12 | 2010 | 23694 | 0.160 |
Why?
|
Ascites | 1 | 2001 | 338 | 0.160 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15728 | 0.160 |
Why?
|
Brain Diseases | 1 | 2007 | 1540 | 0.160 |
Why?
|
Apolipoproteins | 1 | 2000 | 320 | 0.150 |
Why?
|
Biological Transport | 6 | 2002 | 2086 | 0.150 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 389 | 0.150 |
Why?
|
Kinetics | 8 | 2002 | 6380 | 0.150 |
Why?
|
Cholesterol | 4 | 2018 | 2923 | 0.140 |
Why?
|
Metabolic Diseases | 1 | 2024 | 686 | 0.140 |
Why?
|
Bile Acids and Salts | 2 | 1996 | 380 | 0.140 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1902 | 0.140 |
Why?
|
Glutathione Transferase | 2 | 1996 | 565 | 0.140 |
Why?
|
In Situ Nick-End Labeling | 2 | 2010 | 613 | 0.140 |
Why?
|
Colorectal Neoplasms | 2 | 2006 | 6853 | 0.130 |
Why?
|
Humans | 40 | 2024 | 759255 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2004 | 2142 | 0.130 |
Why?
|
Antiviral Agents | 2 | 2018 | 3060 | 0.120 |
Why?
|
Collagenases | 1 | 1995 | 220 | 0.120 |
Why?
|
HIV Infections | 2 | 2020 | 17128 | 0.120 |
Why?
|
Cytotoxins | 1 | 2015 | 153 | 0.120 |
Why?
|
Interleukin-5 | 1 | 2015 | 270 | 0.120 |
Why?
|
Animals | 21 | 2017 | 167838 | 0.120 |
Why?
|
Diffusion | 3 | 2002 | 813 | 0.120 |
Why?
|
Dextran Sulfate | 1 | 2015 | 255 | 0.120 |
Why?
|
Protective Agents | 1 | 2015 | 150 | 0.120 |
Why?
|
Biopsy | 2 | 2021 | 6772 | 0.120 |
Why?
|
Nitrates | 1 | 2015 | 264 | 0.110 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2001 | 1349 | 0.110 |
Why?
|
Retrospective Studies | 8 | 2024 | 80121 | 0.110 |
Why?
|
Rats, Sprague-Dawley | 7 | 2004 | 8157 | 0.110 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1025 | 0.110 |
Why?
|
Biological Transport, Active | 3 | 2001 | 328 | 0.110 |
Why?
|
Neoplasms | 2 | 2021 | 22019 | 0.110 |
Why?
|
Carrier Proteins | 3 | 2002 | 4939 | 0.110 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2015 | 214 | 0.110 |
Why?
|
Lipopolysaccharides | 2 | 2015 | 2213 | 0.110 |
Why?
|
Obesity, Morbid | 1 | 2024 | 1277 | 0.110 |
Why?
|
Bone Density | 1 | 2006 | 3518 | 0.110 |
Why?
|
Apoptosis | 2 | 2010 | 9492 | 0.110 |
Why?
|
Male | 22 | 2024 | 358719 | 0.100 |
Why?
|
Colonic Neoplasms | 1 | 2004 | 2519 | 0.100 |
Why?
|
Superoxide Dismutase | 1 | 2015 | 593 | 0.100 |
Why?
|
Cesarean Section | 1 | 2001 | 1387 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2001 | 2509 | 0.100 |
Why?
|
Middle Aged | 14 | 2024 | 219653 | 0.100 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 620 | 0.100 |
Why?
|
Mitochondria | 1 | 2004 | 3600 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3804 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2001 | 2295 | 0.090 |
Why?
|
Cell Line | 3 | 2015 | 15636 | 0.090 |
Why?
|
Models, Biological | 4 | 2002 | 9466 | 0.090 |
Why?
|
Lymphocytes | 2 | 2017 | 2609 | 0.090 |
Why?
|
Hemorrhage | 1 | 2002 | 3606 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 10827 | 0.090 |
Why?
|
Genital Neoplasms, Female | 1 | 1995 | 538 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6532 | 0.090 |
Why?
|
Serum Albumin, Bovine | 2 | 2001 | 322 | 0.090 |
Why?
|
Liposomes | 3 | 2001 | 776 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2003 | 2940 | 0.080 |
Why?
|
Solubility | 2 | 2002 | 1087 | 0.080 |
Why?
|
Fatty Acid-Binding Proteins | 2 | 2002 | 296 | 0.080 |
Why?
|
Mice | 5 | 2017 | 81138 | 0.080 |
Why?
|
Female | 16 | 2024 | 390240 | 0.080 |
Why?
|
Aorta | 1 | 2017 | 2042 | 0.080 |
Why?
|
Vaccination | 1 | 2001 | 3354 | 0.080 |
Why?
|
Intestinal Mucosa | 2 | 2015 | 3021 | 0.080 |
Why?
|
Collagen | 1 | 2017 | 2635 | 0.080 |
Why?
|
Prevalence | 2 | 2021 | 15641 | 0.080 |
Why?
|
Cell Membrane | 5 | 2000 | 3683 | 0.080 |
Why?
|
Mice, Inbred C57BL | 3 | 2015 | 21981 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4409 | 0.080 |
Why?
|
Lipid Metabolism Disorders | 1 | 2007 | 20 | 0.080 |
Why?
|
Glycoproteins | 1 | 1995 | 2203 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1995 | 951 | 0.070 |
Why?
|
Colon | 1 | 2015 | 1791 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2004 | 6311 | 0.070 |
Why?
|
Azathioprine | 1 | 2008 | 356 | 0.070 |
Why?
|
Spectrometry, Fluorescence | 2 | 2001 | 687 | 0.070 |
Why?
|
Liver Transplantation | 1 | 2018 | 2313 | 0.070 |
Why?
|
Fibrosis | 2 | 2024 | 2041 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2001 | 3190 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3890 | 0.070 |
Why?
|
Signal Transduction | 3 | 2017 | 23362 | 0.070 |
Why?
|
Proteins | 1 | 2001 | 6029 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13309 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12522 | 0.060 |
Why?
|
Hepatitis B e Antigens | 1 | 2006 | 133 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2004 | 6131 | 0.060 |
Why?
|
Osteocalcin | 1 | 2006 | 273 | 0.060 |
Why?
|
Microsomes, Liver | 2 | 1996 | 173 | 0.060 |
Why?
|
Jaundice | 1 | 2005 | 98 | 0.060 |
Why?
|
beta Catenin | 1 | 2010 | 1043 | 0.060 |
Why?
|
Annexin A5 | 1 | 2004 | 103 | 0.060 |
Why?
|
Carrageenan | 1 | 2004 | 71 | 0.060 |
Why?
|
Cytochromes c | 1 | 2004 | 173 | 0.060 |
Why?
|
Particle Size | 2 | 2001 | 1640 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2000 | 4312 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10734 | 0.060 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2004 | 167 | 0.060 |
Why?
|
Cytoprotection | 1 | 2004 | 200 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.060 |
Why?
|
Ovalbumin | 1 | 2005 | 677 | 0.050 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2004 | 172 | 0.050 |
Why?
|
Endotoxemia | 1 | 2004 | 196 | 0.050 |
Why?
|
Prednisone | 1 | 2008 | 1562 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54204 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39216 | 0.050 |
Why?
|
Caspase 3 | 1 | 2004 | 730 | 0.050 |
Why?
|
Hepatitis B virus | 1 | 2006 | 517 | 0.050 |
Why?
|
Hindlimb | 1 | 2004 | 510 | 0.050 |
Why?
|
Weight Loss | 2 | 2024 | 2673 | 0.050 |
Why?
|
Time Factors | 2 | 2020 | 40109 | 0.050 |
Why?
|
Potassium Iodide | 1 | 2001 | 14 | 0.050 |
Why?
|
Heme Oxygenase-1 | 1 | 2004 | 364 | 0.050 |
Why?
|
Thermodynamics | 2 | 1995 | 599 | 0.050 |
Why?
|
Administration, Oral | 1 | 2010 | 4046 | 0.050 |
Why?
|
Cattle | 2 | 2000 | 3844 | 0.050 |
Why?
|
Chemistry, Physical | 1 | 2001 | 154 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5692 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2017 | 14381 | 0.050 |
Why?
|
Energy Transfer | 1 | 2001 | 108 | 0.050 |
Why?
|
Caspases | 1 | 2004 | 878 | 0.050 |
Why?
|
Aged | 8 | 2024 | 168617 | 0.050 |
Why?
|
Chemical Phenomena | 1 | 2001 | 508 | 0.050 |
Why?
|
Ligands | 2 | 2001 | 3275 | 0.050 |
Why?
|
Glucuronosyltransferase | 1 | 2001 | 130 | 0.050 |
Why?
|
Apolipoproteins D | 1 | 2000 | 14 | 0.050 |
Why?
|
Cholic Acid | 1 | 2000 | 31 | 0.050 |
Why?
|
Receptors, Drug | 1 | 1981 | 157 | 0.050 |
Why?
|
Pancreatitis | 1 | 2007 | 1100 | 0.040 |
Why?
|
Eosinophilia | 1 | 2005 | 560 | 0.040 |
Why?
|
Cytokines | 1 | 2015 | 7346 | 0.040 |
Why?
|
Adenine | 1 | 2006 | 976 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13621 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2021 | 525 | 0.040 |
Why?
|
Mathematics | 1 | 2001 | 708 | 0.040 |
Why?
|
Lipoproteins, VLDL | 1 | 1981 | 201 | 0.040 |
Why?
|
Spin Labels | 1 | 2001 | 335 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12268 | 0.040 |
Why?
|
Eating | 1 | 2006 | 1538 | 0.040 |
Why?
|
Sex Distribution | 1 | 2004 | 2294 | 0.040 |
Why?
|
Carbon Radioisotopes | 1 | 2000 | 557 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2007 | 819 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11888 | 0.040 |
Why?
|
Models, Chemical | 1 | 2001 | 615 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2004 | 3604 | 0.040 |
Why?
|
Adult | 9 | 2022 | 219390 | 0.040 |
Why?
|
Patient Simulation | 1 | 2001 | 298 | 0.040 |
Why?
|
Erythrocyte Membrane | 1 | 2000 | 439 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2008 | 2142 | 0.040 |
Why?
|
Fasting | 1 | 2004 | 1603 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2001 | 1849 | 0.040 |
Why?
|
United States | 2 | 2021 | 72237 | 0.040 |
Why?
|
Emergencies | 1 | 2003 | 1217 | 0.040 |
Why?
|
Plasma | 1 | 2000 | 583 | 0.040 |
Why?
|
Health Surveys | 2 | 2004 | 4060 | 0.030 |
Why?
|
Anemia, Myelophthisic | 1 | 1976 | 6 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11058 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2000 | 667 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11833 | 0.030 |
Why?
|
Drug Resistance | 1 | 2021 | 1611 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 1995 | 97 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6496 | 0.030 |
Why?
|
Solutions | 2 | 1996 | 423 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2002 | 10333 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2020 | 988 | 0.030 |
Why?
|
Subcellular Fractions | 1 | 1996 | 531 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2008 | 4168 | 0.030 |
Why?
|
Spleen | 1 | 1981 | 2297 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2023 | 0.030 |
Why?
|
Carcinoembryonic Antigen | 1 | 1995 | 336 | 0.030 |
Why?
|
Risk Factors | 3 | 2006 | 74167 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2010 | 10440 | 0.030 |
Why?
|
Ion Transport | 1 | 1995 | 318 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3724 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2001 | 1914 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2005 | 4435 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2021 | 1870 | 0.030 |
Why?
|
Sex Factors | 1 | 2006 | 10518 | 0.030 |
Why?
|
Buffers | 1 | 1992 | 144 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 1996 | 2558 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 1995 | 633 | 0.030 |
Why?
|
Erythropoiesis | 1 | 1976 | 682 | 0.020 |
Why?
|
Attitude to Health | 1 | 2001 | 2028 | 0.020 |
Why?
|
Viscosity | 1 | 1992 | 335 | 0.020 |
Why?
|
Erythropoietin | 1 | 1976 | 720 | 0.020 |
Why?
|
Comorbidity | 1 | 2006 | 10547 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3150 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1992 | 662 | 0.020 |
Why?
|
Chronic Disease | 1 | 2006 | 9282 | 0.020 |
Why?
|
Membrane Lipids | 1 | 1992 | 251 | 0.020 |
Why?
|
Pregnancy | 2 | 2003 | 29658 | 0.020 |
Why?
|
Membrane Fusion | 1 | 1992 | 266 | 0.020 |
Why?
|
Microbial Collagenase | 1 | 1990 | 113 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7595 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8540 | 0.020 |
Why?
|
Recurrence | 1 | 2002 | 8469 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1981 | 5497 | 0.020 |
Why?
|
Insulin | 1 | 2024 | 6591 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1994 | 3087 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6070 | 0.020 |
Why?
|
Tissue Donors | 1 | 2018 | 2301 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 1976 | 2424 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5500 | 0.020 |
Why?
|
Protein Binding | 1 | 2000 | 9334 | 0.020 |
Why?
|
Lung | 1 | 2005 | 9982 | 0.020 |
Why?
|
Stroke Volume | 1 | 2020 | 5497 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9194 | 0.020 |
Why?
|
Asthma | 1 | 2005 | 6161 | 0.020 |
Why?
|
Bone Marrow | 1 | 1976 | 2918 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2023 | 64879 | 0.020 |
Why?
|
Adolescent | 3 | 2018 | 87560 | 0.020 |
Why?
|
Disease Progression | 1 | 2002 | 13479 | 0.020 |
Why?
|
Inflammation | 1 | 2004 | 10747 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12800 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20031 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24049 | 0.010 |
Why?
|
Child, Preschool | 1 | 2002 | 41935 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21336 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11653 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29561 | 0.010 |
Why?
|
Glycodeoxycholic Acid | 1 | 1996 | 23 | 0.010 |
Why?
|
Taurodeoxycholic Acid | 1 | 1996 | 13 | 0.010 |
Why?
|
Calorimetry | 1 | 1996 | 129 | 0.010 |
Why?
|
Taurochenodeoxycholic Acid | 1 | 1996 | 35 | 0.010 |
Why?
|
Demography | 1 | 2001 | 1648 | 0.010 |
Why?
|
Micelles | 1 | 1996 | 192 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 1996 | 488 | 0.010 |
Why?
|
Permeability | 1 | 1996 | 719 | 0.010 |
Why?
|
Urea | 1 | 1996 | 443 | 0.010 |
Why?
|
Heme | 1 | 1976 | 313 | 0.010 |
Why?
|
Molecular Weight | 1 | 1996 | 2186 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1990 | 5310 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 58483 | 0.010 |
Why?
|
Microvilli | 1 | 1990 | 233 | 0.010 |
Why?
|
Detergents | 1 | 1990 | 235 | 0.010 |
Why?
|
Light | 1 | 1996 | 1343 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1990 | 535 | 0.010 |
Why?
|
Iron | 1 | 1976 | 1785 | 0.000 |
Why?
|
Immunoblotting | 1 | 1990 | 1649 | 0.000 |
Why?
|
DNA | 1 | 1981 | 7237 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1990 | 2474 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2001 | 58867 | 0.000 |
Why?
|
Child | 1 | 2001 | 79623 | 0.000 |
Why?
|
Concepts
(311)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_